MCP
ABBV icon

Mirador Capital Partners’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$11.2M Buy
60,391
+5,667
+10% +$1.05M 1.82% 14
2025
Q1
$11.5M Buy
54,724
+2,534
+5% +$531K 2.01% 13
2024
Q4
$9.27M Sell
52,190
-417
-0.8% -$74.1K 1.68% 14
2024
Q3
$10.4M Buy
52,607
+976
+2% +$193K 1.87% 14
2024
Q2
$8.86M Buy
51,631
+1,651
+3% +$283K 1.67% 14
2024
Q1
$9.1M Buy
49,980
+1,625
+3% +$296K 1.74% 13
2023
Q4
$7.49M Sell
48,355
-1,219
-2% -$189K 1.59% 14
2023
Q3
$7.39M Sell
49,574
-561
-1% -$83.6K 1.68% 10
2023
Q2
$6.75M Buy
50,135
+885
+2% +$119K 1.6% 12
2023
Q1
$7.85M Sell
49,250
-1,513
-3% -$241K 1.86% 13
2022
Q4
$8.2M Buy
50,763
+553
+1% +$89.4K 1.94% 11
2022
Q3
$6.74M Sell
50,210
-1,083
-2% -$145K 1.63% 15
2022
Q2
$7.86M Buy
51,293
+1,493
+3% +$229K 1.85% 13
2022
Q1
$8.07M Buy
49,800
+3,395
+7% +$550K 1.63% 15
2021
Q4
$6.28M Buy
46,405
+3,625
+8% +$491K 1.32% 21
2021
Q3
$4.62M Buy
42,780
+721
+2% +$77.8K 1.05% 28
2021
Q2
$4.74M Buy
42,059
+2,084
+5% +$235K 1.07% 30
2021
Q1
$4.33M Buy
39,975
+2,676
+7% +$290K 1.11% 28
2020
Q4
$4M Buy
37,299
+1,222
+3% +$131K 1.1% 28
2020
Q3
$3.16M Sell
36,077
-1,295
-3% -$113K 0.98% 34
2020
Q2
$3.67M Buy
37,372
+207
+0.6% +$20.3K 1.37% 20
2020
Q1
$3.18M Buy
37,165
+3,751
+11% +$320K 1.33% 22
2019
Q4
$2.96M Sell
33,414
-483
-1% -$42.8K 1.19% 24
2019
Q3
$2.57M Buy
33,897
+1,687
+5% +$128K 1.15% 27
2019
Q2
$2.34M Buy
32,210
+15,819
+97% +$1.15M 1.15% 27
2019
Q1
$1.32M Sell
16,391
-620
-4% -$50K 0.72% 48
2018
Q4
$1.57M Sell
17,011
-2,212
-12% -$204K 0.97% 40
2018
Q3
$1.82M Buy
19,223
+78
+0.4% +$7.38K 0.89% 44
2018
Q2
$1.77M Sell
19,145
-239
-1% -$22.1K 0.97% 36
2018
Q1
$1.87M Sell
19,384
-197
-1% -$19K 1.31% 25
2017
Q4
$1.89M Buy
19,581
+284
+1% +$27.5K 1.04% 34
2017
Q3
$1.74M Buy
19,297
+124
+0.6% +$11.2K 1.02% 36
2017
Q2
$1.36M Sell
19,173
-244
-1% -$17.3K 0.83% 38
2017
Q1
$1.27M Buy
19,417
+7,336
+61% +$478K 0.92% 35
2016
Q4
$757K Sell
12,081
-664
-5% -$41.6K 0.61% 64
2016
Q3
$804K Sell
12,745
-82
-0.6% -$5.17K 0.71% 51
2016
Q2
$854K Buy
12,827
+32
+0.3% +$2.13K 0.86% 45
2016
Q1
$731K Buy
+12,795
New +$731K 0.81% 47